New cost-friendly blood test can detect genetic mutations, may help improve cancer treatment
Scientists from Stanford University have developed a new type of economical blood test that is capable for quickly tracking cancer growth and spread. This test only requires a fraction of tube of blood and can detect genetic mutations in tiny amounts of DNA released from cancer cells in the blood. The study published in the journal of Molecular Diagnostics revealed it.
"For monitoring patient tumours, only a handful of blood tests are available which are limited to only several types of cancers. Nearly all cancer patients require monitoring by whole body imaging, which can be costly, complex, and time-consuming," said lead investigator Hanlee P. Ji, Associate Professor at Stanford University in the US.
Also Read: Help us bring little Aadya home
"In contrast, molecular tests like the one we have developed will enable patients to be monitored at every visit, and thus have the potential for quickly tracking cancer growth and spread," Ji added.
The test, which is called single colour digital PCR, can detect as few as three mutation-bearing molecules in a single reaction, the study said.
"Moreover, the test's rapid turnaround and relatively low cost, especially compared to next-generation DNA sequencing, provide a potential opportunity for universal monitoring of more patients than is currently done," Ji said.
The test is very simple to set up and perform without requiring extensive training. Therefore, it can be used by anyone. The lead author Christina Wood Bouwens of the Stanford Genome Technology Center said.
(With IANS Inputs)